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journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORButtock verrucous carcinoma treated by
intra-arterial infusion chemotherapyA 66-year-old woman presented with an ulcerated endo-
phytic mass on the right buttock of 4 years’ duration
(Fig. 1A) and an enlarging mass over the right foot for 6
months following a traumatic ulcer (Fig. 1C). The patient
lived on the southwestern coast of Taiwan, where people
drink deep well water. Hyperpigmentation, arsenical
keratosis, and multiple Bowen’s diseases were noted on her
chest and left leg. She had spent much time sitting during
the past l0 years because of knees compromised by
arthritis. Dermatologic examination revealed a 6 cm  5 cmFigure 1. Right buttock verrucous carcinoma (A) before and (B) a
hyperkeratosis (arrows) (C) before and (D) after treatment.
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http://dx.doi.org/10.1016/j.kjms.2013.09.002firm nodule, with an ulcer on the right buttock and a
5 cm  5 cm nodule on the right foot. There was no regional
lymphadenopathy. Biopsy revealed verrucous carcinoma of
the right buttock and verrucous hyperplasia of the right
foot. X-ray examination and pelvic CT showed no bony
destruction. She was referred for regional chemotherapy.
The catheter (Jet Port Plus Allround catheter PFM, Ko¨ln,
Germany) was inserted through the profunda femoral ar-
tery into the abdominal aorta. The tip of the catheter was
placed at about the level of the third lumbar vertebra. Thefter treatment. Right foot verrucous hyperplasia with punctate
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Letter to the Editor 433patient was infused continuously with 50 mg of metho-
trexate every 24 hours using a pump (CADD-1, Deltec, St.
Paul MN, USA) accompanied by intramuscular injection of
leucovorin (6 mg) every 6 hours. The infusion was termi-
nated when the white blood cell count dropped to 2880/uL
(nadir) and 425 mg of methotrexate was given in total. The
foot tumor disappeared 2 weeks later; the buttock tumor
regressed, and the ulceration gradually healed. Bowen’s
disease on the left lower leg and arsenical keratosis also
disappeared after therapy (Fig. 1C and D). Then, the pa-
tient received a weekly infusion of 50 mg of methotrexate,
until the wound healed completely after 8 months (Fig. 1B
and D). The patient was in sustained complete remission 8
years and 10 months after treatment, when she died.
Verrucous carcinoma may develop at the site of chronic
irritation and inflammation, such as decubitus ulcers [1,2].
Arsenic is a well-documented human carcinogen. Bowen’s
disease, squamous cell carcinoma, and basal cell carci-
noma are the most common cutaneous cancers in chronic
arsenism. Only one case of verrucous carcinoma due to
arsenic ingestion has been reported [3]. The coexistence of
verrucous carcinoma and Bowen’s disease on the same
patient may be explained by the formation of multiple
tumors induced by chronic arsenism and an inflammatory
process.
The treatment of choice for verrucous carcinoma is wide
excision [1,4]. Other modalities including topical chemo-
therapy, laser ablation, photodynamic therapy, and immu-
notherapy have been attempted [1,2,4]. Radiotherapy and
systemic chemotherapy have limited application [1,4].
Recently, we showed that methotrexate given intra-
arterially has excellent effects of preservation of
cosmetic and functional integrity in verrucous carcinoma of
the penis, lip, and thumb [5]. This case further confirmed
the effectiveness of intra-arterial methotrexate infusion in
the management of verrucous carcinoma, with concomitant
remission of arsenical dermatosis. It offered an option in
treating verrucous carcinoma for patients with unresect-
able lesions, or for those who are unwilling to undergo
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